Printer Friendly

Mylan unveils generic Adderall ADHD tablets in the US.

M2 EQUITYBITES-November 20, 2015-Mylan unveils generic Adderall ADHD tablets in the US

(C)2015 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical company Mylan NV (Nasdaq:MYL TASE:MYL) reported on Thursday the availability of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg in the US market.

The company said Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (mixed salts of a single entity amphetamine product), 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg are the generic version of Teva's Adderall Tablets.

According to the company, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets' NDA has passed the final approval from the US Food and Drug Administration (FDA) for the treatment of attention deficit hyperactivity disorder (ADHD).

For the 12 months ending 30 September 2015, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (mixed salts of a single entity amphetamine product), 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg, had US sales of about USD570.4m, according to IMS Health.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Nov 20, 2015
Words:214
Previous Article:Alfa Laval awarded SEK65m air heat exchangers order by Spanish refinery.
Next Article:Nickel Mountain Group makes changes in management team.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters